Actively Recruiting
Polycystic Kidney Disease Data Repository
Led by The Rogosin Institute · Updated on 2025-11-12
1000
Participants Needed
1
Research Sites
1465 weeks
Total Duration
On this page
Sponsors
T
The Rogosin Institute
Lead Sponsor
W
Weill Medical College of Cornell University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Autosomal dominant polycystic kidney disease (PKD) is the most common inherited kidney disease, affecting more than 400,000 people in the U.S. and 5 million people worldwide. PKD is the 4th most common cause of kidney failure requiring dialysis and/or transplantation. Over half of all PKD patients develop kidney failure by age 60 years, although age of onset of kidney disease varies widely, even among members of the same family. Despite the fact this is a relatively common problem, relatively few patients have been studied for a sufficient period of time to fully understand how patients are affected over the course of their lifetime. The reason for creating this repository is to collect information about PKD so that the investigators may fully understand its complications, including high blood pressure, heart attack, and stroke. This information may also aid in the development of improved treatment strategies.
CONDITIONS
Official Title
Polycystic Kidney Disease Data Repository
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Any person, age 18 or older, with previously diagnosed ADPKD is eligible to participate.
You will not qualify if you...
- Inability to provide informed consent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Rogosin Institute
New York, New York, United States, 10021
Actively Recruiting
Research Team
J
Jon Blumenfeld, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here